Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.1295 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Pharmaceuticals Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024
Via ACCESSWIRE
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
Via ACCESSWIRE
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels
Via ACCESSWIRE
Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay
Via ACCESSWIRE
Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
Via ACCESSWIRE
Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Via ACCESSWIRE
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform
Via ACCESSWIRE
ZOM Stock Earnings: Zomedica Misses Revenue for Q1 2024
ZOM stock results show that Zomedica missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
Via ACCESSWIRE
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
Via ACCESSWIRE
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
Via Benzinga
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning! 
Via InvestorPlace
Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024
Via ACCESSWIRE
Zomedica Corp. (NYSE American: ZOM) Featured in Coverage of the EF Hutton Annual Global Conference
Via Investor Brand Network
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
Via ACCESSWIRE
ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023
ZOM stock results show that Zomedica beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
Via ACCESSWIRE
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
Via ACCESSWIRE
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
Via ACCESSWIRE
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Via ACCESSWIRE
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Via ACCESSWIRE
Earnings Scheduled For April 1, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. 
Via Benzinga
Zomedica Provides NYSE American Listing Update
Via ACCESSWIRE
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
Via ACCESSWIRE
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
Via ACCESSWIRE
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
Via ACCESSWIRE
3 High-Reward Penny Stocks to Uncover Big Gains
Dive into the realm of high-reward penny stocks. The article gives the insights you need to spot quality plays and make informed decisions. 
Via InvestorPlace
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
Via ACCESSWIRE
7 Penny Stocks to Buy on the Dip: February 2024
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.